SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 9 filers reported holding SEAGEN INC in Q4 2023. The put-call ratio across all filers is 0.99 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,733,416 | +10.2% | 17,598 | -0.0% | 2.36% | -0.2% |
| Q2 2023 | $3,388,066 | +46644.8% | 17,604 | -89.0% | 2.37% | +29475.0% |
| Q1 2023 | $7,248 | +218.2% | 160,000 | +802.5% | 0.01% | -99.5% |
| Q4 2022 | $2,278 | -99.9% | 17,728 | -0.0% | 1.62% | -20.9% |
| Q3 2022 | $2,426,000 | -24.9% | 17,730 | -2.8% | 2.05% | -16.6% |
| Q2 2022 | $3,229,000 | +22.8% | 18,250 | -0.0% | 2.46% | +62.6% |
| Q1 2022 | $2,630,000 | -6.7% | 18,258 | +0.2% | 1.51% | +15.3% |
| Q4 2021 | $2,818,000 | -8.9% | 18,227 | -0.0% | 1.31% | +16.5% |
| Q3 2021 | $3,095,000 | +8.2% | 18,229 | +0.6% | 1.12% | +18.2% |
| Q2 2021 | $2,860,000 | +13.7% | 18,117 | +0.0% | 0.95% | -39.1% |
| Q1 2021 | $2,515,000 | -46.3% | 18,113 | -24.3% | 1.56% | -39.0% |
| Q3 2020 | $4,684,000 | – | 23,938 | – | 2.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |